Literature DB >> 7684415

Regulation of the tyrosine kinase-dependent adhesion pathway in human lymphocytes through CD45.

N Wagner1, P Engel, T F Tedder.   

Abstract

Cell-cell adhesive interactions involve numerous receptor/ligand interactions that play a crucial role in the development of immune function. Engagement of multiple cell-surface molecules on B lymphocytes generates intracellular signals through a tyrosine kinase-dependent pathway that activates cell-surface adhesion receptors and thereby induces homotypic cell-cell adhesion. Homotypic adhesion is mediated in part through LFA-1/ICAM-1 and other heretofore unknown adhesion receptors. In this study, evidence of a regulatory role for CD45 in the induction of homotypic adhesion is suggested. A new mAb (HAB-1) was developed that inhibits homotypic adhesion in B cell lines induced through MHC class I and class II, CD19, CD20, CD21, CD40, and Leu-13 cell-surface molecules. Although binding of this mAb strongly inhibited cell-surface Ag-induced homotypic adhesion at mAb concentrations as low as 0.1 microgram/ml, it exhibited no effect on homotypic adhesion induced by phorbol esters. Binding of the HAB-1 mAb to lymphocytes altered the pattern of cellular protein tyrosine phosphorylation, but did not have a global inhibitory effect on cell activation because it did not have major effects on the growth of mitogen-activated lymphocytes. Immunoprecipitation studies revealed that the HAB-1 mAb identified an epitope present on all isoforms of CD45. The HAB-1 mAb may identify a unique epitope of CD45 because this mAb had a unique staining pattern when assessed by indirect immunofluorescence staining. The HAB-1 mAb was similar to some other CD45 mAb that have the capacity to amplify CD2-induced proliferation of blood lymphocytes. However, only 1 of 12 other anti-CD45 mAb tested had a similar inhibitory effect on adhesion. Homotypic adhesion of lymphocytes may therefore be governed by a regulatory system of cell-surface molecules that generate positive and negative signals that either trigger adhesion or, like CD45, directly down-regulate adhesion. This highlights the significance of adhesive events that result from surface molecules being engaged by their natural ligands during lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells.

Authors:  François Spertini; Veronique Perret-Menoud; Nathalie Barbier; Talal Chatila; Catherine Barbey; Blaise Corthesy
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

2.  Integrin CD11a cytoplasmic tail interacts with the CD45 membrane-proximal protein tyrosine phosphatase domain 1.

Authors:  Xin Geng; Ren-Hong Tang; S K Alex Law; Suet-Mien Tan
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

3.  Locomotor phenotypes of unstimulated CD45RAhigh and CD45ROhigh CD4+ and CD8+ lymphocytes in three-dimensional collagen lattices.

Authors:  P Friedl; P B Noble; E D Shields; K S Zänker
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

4.  Carbohydrate specificity of IgM autoantibodies to CD45 in systemic lupus erythematosus.

Authors:  P D Fernsten; J K Czyzyk; T Mimura; J B Winfield
Journal:  Mol Biol Rep       Date:  1994       Impact factor: 2.316

5.  The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.

Authors:  A Imura; T Hori; K Imada; T Ishikawa; Y Tanaka; M Maeda; S Imamura; T Uchiyama
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

6.  Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase.

Authors:  A G Arroyo; M R Campanero; P Sánchez-Mateos; J M Zapata; M A Ursa; M A del Pozo; F Sánchez-Madrid
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.